Cargando…
MetfOrmin BenefIts Lower Extremities with Intermittent Claudication (MOBILE IC): randomized clinical trial protocol
BACKGROUND: Peripheral artery disease (PAD) affects over 230 million people worldwide and is due to systemic atherosclerosis with etiology linked to chronic inflammation, hypertension, and smoking status. PAD is associated with walking impairment and mobility loss as well as a high prevalence of cor...
Autores principales: | Reitz, Katherine M., Althouse, Andrew D., Forman, Daniel E., Zuckerbraun, Brian S., Vodovotz, Yoram, Zamora, Ruben, Raffai, Robert L., Hall, Daniel E., Tzeng, Edith |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862509/ https://www.ncbi.nlm.nih.gov/pubmed/36681798 http://dx.doi.org/10.1186/s12872-023-03047-8 |
Ejemplares similares
-
Metformin in adults with type 1 diabetes: Design and methods of REducing with MetfOrmin Vascular Adverse Lesions (REMOVAL): An international multicentre trial
por: Petrie, John R., et al.
Publicado: (2017) -
Cardiometabolic risk factors, peripheral arterial tonometry and metformin in adults with type 1 diabetes participating in the REducing with MetfOrmin Vascular Adverse Lesions trial
por: Chen, David, et al.
Publicado: (2023) -
Intermittent Claudication
Publicado: (1908) -
Is Montelukast Benefical in Children With Atopic Dermatitis?
por: Lee, Ai-Young
Publicado: (2016) -
Intermittent Claudication in Hypertensive Men
por: Ramsay, L. E.
Publicado: (1979)